Received: 28 September 2021
Accepted: 8 November 2021
First Online: 19 November 2021
: All the ethical guidelines and principles placed in the Declaration of Helsinki and others, essential to address the ethical aspects of the research commenced in humans were taken into account. Accordingly, the study protocol was approved by the Ethical Clearance Board of the College of Medicine and Health Sciences of Debre-Tabor University with ref. no. of SCHO/MED/597/2021. Before any attempt at an interview, written informed consent was obtained from each respondent. Their participation was voluntary and they were informed about their right to withdraw from responding whenever they like and not to respond to the questions they want or not to obtain in due course were confidentially stored. Those study individuals, who suffered from glaucoma and its complications, were advised to disclose the problem to their physicians since the problem might be solved either by pharmacologic or other psychological therapy.
: Not applicable.
: The authors declared that they have no competing interests.